CompletedNot Applicable

Pediatric NMOSD Observational Study

United States100 participantsStarted 2018-02-01

Plain-language summary

This study is being done to develop a database of pediatric patients in order to study the cause, early detection and best treatment for neuromyelitis optica spectrum disorder (NMOSD) in pediatric patients.

Who can participate

Age range2 Years – 17 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * AQP4 positive * Ability to give informed consent by patient or caregiver Exclusion Criteria: \- Inability to complete required forms via phone, mail, or email.

What they're measuring

Time to relapse

Timeframe: One year.

Trial details

NCT IDNCT03766347

SponsorMayo Clinic

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-04-03

View on ClinicalTrials.gov More Neuromyelitis Optica trials